nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—ABCG2—Cladribine—multiple sclerosis	0.119	0.172	CbGbCtD
Telmisartan—ABCG2—Mitoxantrone—multiple sclerosis	0.0865	0.125	CbGbCtD
Telmisartan—SLCO1B3—Methotrexate—multiple sclerosis	0.0779	0.113	CbGbCtD
Telmisartan—ABCC2—Dexamethasone—multiple sclerosis	0.0496	0.0719	CbGbCtD
Telmisartan—ABCG2—Dexamethasone—multiple sclerosis	0.0448	0.065	CbGbCtD
Telmisartan—ABCB1—Methylprednisolone—multiple sclerosis	0.0428	0.062	CbGbCtD
Telmisartan—ABCC2—Methotrexate—multiple sclerosis	0.0399	0.0578	CbGbCtD
Telmisartan—ABCG2—Methotrexate—multiple sclerosis	0.036	0.0523	CbGbCtD
Telmisartan—CYP2C19—Prednisone—multiple sclerosis	0.0321	0.0465	CbGbCtD
Telmisartan—ABCB1—Mitoxantrone—multiple sclerosis	0.0312	0.0452	CbGbCtD
Telmisartan—ABCB1—Betamethasone—multiple sclerosis	0.0278	0.0403	CbGbCtD
Telmisartan—ABCB1—Prednisolone—multiple sclerosis	0.0274	0.0398	CbGbCtD
Telmisartan—ABCB1—Prednisone—multiple sclerosis	0.0259	0.0376	CbGbCtD
Telmisartan—CYP2C19—Dexamethasone—multiple sclerosis	0.02	0.0291	CbGbCtD
Telmisartan—ABCB1—Dexamethasone—multiple sclerosis	0.0162	0.0234	CbGbCtD
Telmisartan—ABCB1—Methotrexate—multiple sclerosis	0.013	0.0188	CbGbCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00022	0.00245	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000214	0.00238	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000214	0.00238	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000213	0.00236	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000207	0.0023	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CCR5—multiple sclerosis	0.000199	0.00221	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—FAS—multiple sclerosis	0.000199	0.00221	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000194	0.00216	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.000191	0.00213	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000191	0.00212	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—ZNF746—multiple sclerosis	0.00019	0.00211	CbGpPWpGaD
Telmisartan—PPARG—Wnt Signaling Pathway Netpath—MYC—multiple sclerosis	0.000188	0.00209	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000187	0.00208	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.000186	0.00207	CbGpPWpGaD
Telmisartan—PPARG—Wnt Signaling Pathway Netpath—MAPK1—multiple sclerosis	0.000184	0.00205	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000183	0.00204	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—multiple sclerosis	0.000181	0.00201	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—TGFB1—multiple sclerosis	0.000181	0.00201	CbGpPWpGaD
Telmisartan—Haematuria—Methotrexate—multiple sclerosis	0.000181	0.000819	CcSEcCtD
Telmisartan—Shock—Triamcinolone—multiple sclerosis	0.00018	0.000816	CcSEcCtD
Telmisartan—Insomnia—Prednisolone—multiple sclerosis	0.00018	0.000816	CcSEcCtD
Telmisartan—Shock—Methylprednisolone—multiple sclerosis	0.000179	0.000815	CcSEcCtD
Telmisartan—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000179	0.000813	CcSEcCtD
Telmisartan—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000179	0.000812	CcSEcCtD
Telmisartan—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000179	0.000811	CcSEcCtD
Telmisartan—Loss of consciousness—Betamethasone—multiple sclerosis	0.000179	0.000811	CcSEcCtD
Telmisartan—Epistaxis—Methotrexate—multiple sclerosis	0.000179	0.00081	CcSEcCtD
Telmisartan—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000179	0.00081	CcSEcCtD
Telmisartan—Paraesthesia—Prednisolone—multiple sclerosis	0.000179	0.00081	CcSEcCtD
Telmisartan—Tachycardia—Triamcinolone—multiple sclerosis	0.000178	0.00081	CcSEcCtD
Telmisartan—Mental disorder—Prednisone—multiple sclerosis	0.000178	0.000808	CcSEcCtD
Telmisartan—Nausea—Azathioprine—multiple sclerosis	0.000178	0.000808	CcSEcCtD
Telmisartan—Tachycardia—Methylprednisolone—multiple sclerosis	0.000178	0.000808	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	0.000178	0.00198	CbGpPWpGaD
Telmisartan—Skin disorder—Methylprednisolone—multiple sclerosis	0.000177	0.000804	CcSEcCtD
Telmisartan—Erythema—Prednisone—multiple sclerosis	0.000177	0.000803	CcSEcCtD
Telmisartan—Malnutrition—Prednisone—multiple sclerosis	0.000177	0.000803	CcSEcCtD
Telmisartan—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000177	0.000802	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.000176	0.00196	CbGpPWpGaD
Telmisartan—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000176	0.0008	CcSEcCtD
Telmisartan—Hypertension—Betamethasone—multiple sclerosis	0.000176	0.000796	CcSEcCtD
Telmisartan—Hypertension—Dexamethasone—multiple sclerosis	0.000176	0.000796	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—CCL3—multiple sclerosis	0.000174	0.00194	CbGpPWpGaD
Telmisartan—Asthenia—Mitoxantrone—multiple sclerosis	0.000174	0.000789	CcSEcCtD
Telmisartan—PPARG—Gene Expression—PTBP1—multiple sclerosis	0.000174	0.00193	CbGpPWpGaD
Telmisartan—Myalgia—Betamethasone—multiple sclerosis	0.000173	0.000785	CcSEcCtD
Telmisartan—Myalgia—Dexamethasone—multiple sclerosis	0.000173	0.000785	CcSEcCtD
Telmisartan—Anxiety—Betamethasone—multiple sclerosis	0.000172	0.000783	CcSEcCtD
Telmisartan—Anxiety—Dexamethasone—multiple sclerosis	0.000172	0.000783	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000172	0.00191	CbGpPWpGaD
Telmisartan—Discomfort—Betamethasone—multiple sclerosis	0.000171	0.000776	CcSEcCtD
Telmisartan—Discomfort—Dexamethasone—multiple sclerosis	0.000171	0.000776	CcSEcCtD
Telmisartan—Hypotension—Methylprednisolone—multiple sclerosis	0.00017	0.000774	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—S1PR1—multiple sclerosis	0.00017	0.00189	CbGpPWpGaD
Telmisartan—Pain—Prednisolone—multiple sclerosis	0.00017	0.000772	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—CD40—multiple sclerosis	0.00017	0.00189	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—TNF—multiple sclerosis	0.000169	0.00188	CbGpPWpGaD
Telmisartan—Pharyngitis—Methotrexate—multiple sclerosis	0.000169	0.000765	CcSEcCtD
Telmisartan—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000168	0.000762	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—PTGER4—multiple sclerosis	0.000168	0.00186	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.000167	0.00186	CbGpPWpGaD
Telmisartan—Urethral disorder—Methotrexate—multiple sclerosis	0.000167	0.000756	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000167	0.000756	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000166	0.000754	CcSEcCtD
Telmisartan—Oedema—Betamethasone—multiple sclerosis	0.000166	0.000753	CcSEcCtD
Telmisartan—Oedema—Dexamethasone—multiple sclerosis	0.000166	0.000753	CcSEcCtD
Telmisartan—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000166	0.000753	CcSEcCtD
Telmisartan—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000166	0.000753	CcSEcCtD
Telmisartan—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000166	0.000752	CcSEcCtD
Telmisartan—Insomnia—Triamcinolone—multiple sclerosis	0.000165	0.00075	CcSEcCtD
Telmisartan—Insomnia—Methylprednisolone—multiple sclerosis	0.000165	0.000749	CcSEcCtD
Telmisartan—Infection—Dexamethasone—multiple sclerosis	0.000165	0.000748	CcSEcCtD
Telmisartan—Infection—Betamethasone—multiple sclerosis	0.000165	0.000748	CcSEcCtD
Telmisartan—Ill-defined disorder—Prednisone—multiple sclerosis	0.000164	0.000745	CcSEcCtD
Telmisartan—Paraesthesia—Triamcinolone—multiple sclerosis	0.000164	0.000745	CcSEcCtD
Telmisartan—Feeling abnormal—Prednisolone—multiple sclerosis	0.000164	0.000744	CcSEcCtD
Telmisartan—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000164	0.000743	CcSEcCtD
Telmisartan—Visual impairment—Methotrexate—multiple sclerosis	0.000164	0.000743	CcSEcCtD
Telmisartan—Anaemia—Prednisone—multiple sclerosis	0.000164	0.000743	CcSEcCtD
Telmisartan—Shock—Betamethasone—multiple sclerosis	0.000163	0.000741	CcSEcCtD
Telmisartan—Shock—Dexamethasone—multiple sclerosis	0.000163	0.000741	CcSEcCtD
Telmisartan—Dyspnoea—Triamcinolone—multiple sclerosis	0.000163	0.00074	CcSEcCtD
Telmisartan—Nervous system disorder—Betamethasone—multiple sclerosis	0.000163	0.000738	CcSEcCtD
Telmisartan—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000163	0.000738	CcSEcCtD
Telmisartan—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000162	0.000737	CcSEcCtD
Telmisartan—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000162	0.000737	CcSEcCtD
Telmisartan—Tachycardia—Dexamethasone—multiple sclerosis	0.000162	0.000735	CcSEcCtD
Telmisartan—Tachycardia—Betamethasone—multiple sclerosis	0.000162	0.000735	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—CXCR3—multiple sclerosis	0.000162	0.0018	CbGpPWpGaD
Telmisartan—Angioedema—Prednisone—multiple sclerosis	0.000162	0.000734	CcSEcCtD
Telmisartan—Dyspepsia—Triamcinolone—multiple sclerosis	0.000161	0.00073	CcSEcCtD
Telmisartan—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000161	0.000729	CcSEcCtD
Telmisartan—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00016	0.000728	CcSEcCtD
Telmisartan—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00016	0.000728	CcSEcCtD
Telmisartan—PPARG—Signaling events mediated by HDAC Class I—STAT3—multiple sclerosis	0.00016	0.00178	CbGpPWpGaD
Telmisartan—Malaise—Prednisone—multiple sclerosis	0.00016	0.000724	CcSEcCtD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000159	0.00177	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—RGS1—multiple sclerosis	0.000159	0.00177	CbGpPWpGaD
Telmisartan—Vertigo—Prednisone—multiple sclerosis	0.000159	0.000722	CcSEcCtD
Telmisartan—Eye disorder—Methotrexate—multiple sclerosis	0.000159	0.000721	CcSEcCtD
Telmisartan—Syncope—Prednisone—multiple sclerosis	0.000159	0.00072	CcSEcCtD
Telmisartan—Tinnitus—Methotrexate—multiple sclerosis	0.000158	0.000719	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism—SRM—multiple sclerosis	0.000158	0.00176	CbGpPWpGaD
Telmisartan—Anorexia—Betamethasone—multiple sclerosis	0.000158	0.000718	CcSEcCtD
Telmisartan—Anorexia—Dexamethasone—multiple sclerosis	0.000158	0.000718	CcSEcCtD
Telmisartan—Urticaria—Prednisolone—multiple sclerosis	0.000158	0.000717	CcSEcCtD
Telmisartan—Cardiac disorder—Methotrexate—multiple sclerosis	0.000158	0.000716	CcSEcCtD
Telmisartan—Fatigue—Triamcinolone—multiple sclerosis	0.000158	0.000715	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—CCR2—multiple sclerosis	0.000157	0.00175	CbGpPWpGaD
Telmisartan—Fatigue—Methylprednisolone—multiple sclerosis	0.000157	0.000714	CcSEcCtD
Telmisartan—Pain—Triamcinolone—multiple sclerosis	0.000156	0.00071	CcSEcCtD
Telmisartan—Loss of consciousness—Prednisone—multiple sclerosis	0.000156	0.000706	CcSEcCtD
Telmisartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000156	0.00173	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.000155	0.00173	CbGpPWpGaD
Telmisartan—Hypotension—Betamethasone—multiple sclerosis	0.000155	0.000703	CcSEcCtD
Telmisartan—Hypotension—Dexamethasone—multiple sclerosis	0.000155	0.000703	CcSEcCtD
Telmisartan—Angiopathy—Methotrexate—multiple sclerosis	0.000154	0.0007	CcSEcCtD
Telmisartan—Vomiting—Mitoxantrone—multiple sclerosis	0.000154	0.000699	CcSEcCtD
Telmisartan—Immune system disorder—Methotrexate—multiple sclerosis	0.000154	0.000697	CcSEcCtD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000153	0.00171	CbGpPWpGaD
Telmisartan—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000153	0.000695	CcSEcCtD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000153	0.0017	CbGpPWpGaD
Telmisartan—Hypertension—Prednisone—multiple sclerosis	0.000153	0.000694	CcSEcCtD
Telmisartan—Rash—Mitoxantrone—multiple sclerosis	0.000153	0.000693	CcSEcCtD
Telmisartan—Dermatitis—Mitoxantrone—multiple sclerosis	0.000153	0.000693	CcSEcCtD
Telmisartan—Chills—Methotrexate—multiple sclerosis	0.000152	0.000692	CcSEcCtD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.000152	0.00169	CbGpPWpGaD
Telmisartan—Headache—Mitoxantrone—multiple sclerosis	0.000152	0.000689	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000151	0.000686	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000151	0.000686	CcSEcCtD
Telmisartan—AGTR1—GPCR downstream signaling—GPR65—multiple sclerosis	0.000151	0.00168	CbGpPWpGaD
Telmisartan—Myalgia—Prednisone—multiple sclerosis	0.000151	0.000684	CcSEcCtD
Telmisartan—Arthralgia—Prednisone—multiple sclerosis	0.000151	0.000684	CcSEcCtD
Telmisartan—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000151	0.000684	CcSEcCtD
Telmisartan—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00015	0.000682	CcSEcCtD
Telmisartan—Anxiety—Prednisone—multiple sclerosis	0.00015	0.000682	CcSEcCtD
Telmisartan—Insomnia—Betamethasone—multiple sclerosis	0.00015	0.000681	CcSEcCtD
Telmisartan—Insomnia—Dexamethasone—multiple sclerosis	0.00015	0.000681	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00015	0.000679	CcSEcCtD
Telmisartan—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000149	0.000677	CcSEcCtD
Telmisartan—Paraesthesia—Betamethasone—multiple sclerosis	0.000149	0.000676	CcSEcCtD
Telmisartan—Paraesthesia—Dexamethasone—multiple sclerosis	0.000149	0.000676	CcSEcCtD
Telmisartan—Discomfort—Prednisone—multiple sclerosis	0.000149	0.000676	CcSEcCtD
Telmisartan—Mental disorder—Methotrexate—multiple sclerosis	0.000149	0.000676	CcSEcCtD
Telmisartan—Malnutrition—Methotrexate—multiple sclerosis	0.000148	0.000671	CcSEcCtD
Telmisartan—Erythema—Methotrexate—multiple sclerosis	0.000148	0.000671	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000148	0.00164	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.000147	0.00164	CbGpPWpGaD
Telmisartan—Hypersensitivity—Prednisolone—multiple sclerosis	0.000146	0.000665	CcSEcCtD
Telmisartan—Dyspepsia—Betamethasone—multiple sclerosis	0.000146	0.000663	CcSEcCtD
Telmisartan—Dyspepsia—Dexamethasone—multiple sclerosis	0.000146	0.000663	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—CNR1—multiple sclerosis	0.000145	0.00162	CbGpPWpGaD
Telmisartan—Urticaria—Triamcinolone—multiple sclerosis	0.000145	0.000659	CcSEcCtD
Telmisartan—Urticaria—Methylprednisolone—multiple sclerosis	0.000145	0.000658	CcSEcCtD
Telmisartan—Dysgeusia—Methotrexate—multiple sclerosis	0.000145	0.000657	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—RGS1—multiple sclerosis	0.000145	0.00161	CbGpPWpGaD
Telmisartan—Body temperature increased—Triamcinolone—multiple sclerosis	0.000145	0.000656	CcSEcCtD
Telmisartan—Anaphylactic shock—Prednisone—multiple sclerosis	0.000144	0.000656	CcSEcCtD
Telmisartan—Oedema—Prednisone—multiple sclerosis	0.000144	0.000656	CcSEcCtD
Telmisartan—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000144	0.000654	CcSEcCtD
Telmisartan—Decreased appetite—Dexamethasone—multiple sclerosis	0.000144	0.000654	CcSEcCtD
Telmisartan—Decreased appetite—Betamethasone—multiple sclerosis	0.000144	0.000654	CcSEcCtD
Telmisartan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	0.000144	0.0016	CbGpPWpGaD
Telmisartan—Nausea—Mitoxantrone—multiple sclerosis	0.000144	0.000653	CcSEcCtD
Telmisartan—Infection—Prednisone—multiple sclerosis	0.000144	0.000651	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000143	0.00065	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000143	0.00065	CcSEcCtD
Telmisartan—Back pain—Methotrexate—multiple sclerosis	0.000143	0.000649	CcSEcCtD
Telmisartan—Fatigue—Dexamethasone—multiple sclerosis	0.000143	0.000649	CcSEcCtD
Telmisartan—Fatigue—Betamethasone—multiple sclerosis	0.000143	0.000649	CcSEcCtD
Telmisartan—Shock—Prednisone—multiple sclerosis	0.000142	0.000645	CcSEcCtD
Telmisartan—Pain—Dexamethasone—multiple sclerosis	0.000142	0.000644	CcSEcCtD
Telmisartan—Pain—Betamethasone—multiple sclerosis	0.000142	0.000644	CcSEcCtD
Telmisartan—Nervous system disorder—Prednisone—multiple sclerosis	0.000142	0.000643	CcSEcCtD
Telmisartan—Tachycardia—Prednisone—multiple sclerosis	0.000141	0.00064	CcSEcCtD
Telmisartan—Skin disorder—Prednisone—multiple sclerosis	0.00014	0.000637	CcSEcCtD
Telmisartan—PPARG—Circadian rythm related genes—FAS—multiple sclerosis	0.00014	0.00156	CbGpPWpGaD
Telmisartan—Hyperhidrosis—Prednisone—multiple sclerosis	0.00014	0.000634	CcSEcCtD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000139	0.00154	CbGpPWpGaD
Telmisartan—PPARG—Signaling events mediated by HDAC Class I—TNF—multiple sclerosis	0.000138	0.00154	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000138	0.00154	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000138	0.00154	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	0.000138	0.00153	CbGpPWpGaD
Telmisartan—Anorexia—Prednisone—multiple sclerosis	0.000138	0.000625	CcSEcCtD
Telmisartan—PPARG—Developmental Biology—PRNP—multiple sclerosis	0.000137	0.00153	CbGpPWpGaD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—multiple sclerosis	0.000137	0.00153	CbGpPWpGaD
Telmisartan—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000137	0.000623	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—GPR65—multiple sclerosis	0.000137	0.00152	CbGpPWpGaD
Telmisartan—Anaemia—Methotrexate—multiple sclerosis	0.000137	0.000621	CcSEcCtD
Telmisartan—Feeling abnormal—Betamethasone—multiple sclerosis	0.000137	0.00062	CcSEcCtD
Telmisartan—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000137	0.00062	CcSEcCtD
Telmisartan—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000136	0.000616	CcSEcCtD
Telmisartan—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000136	0.000616	CcSEcCtD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000136	0.00151	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—SRM—multiple sclerosis	0.000135	0.0015	CbGpPWpGaD
Telmisartan—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000135	0.000611	CcSEcCtD
Telmisartan—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000134	0.00061	CcSEcCtD
Telmisartan—Malaise—Methotrexate—multiple sclerosis	0.000133	0.000605	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000133	0.00148	CbGpPWpGaD
Telmisartan—Vertigo—Methotrexate—multiple sclerosis	0.000133	0.000603	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—CD86—multiple sclerosis	0.000133	0.00147	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—LINGO1—multiple sclerosis	0.000133	0.00147	CbGpPWpGaD
Telmisartan—Urticaria—Dexamethasone—multiple sclerosis	0.000132	0.000598	CcSEcCtD
Telmisartan—Urticaria—Betamethasone—multiple sclerosis	0.000132	0.000598	CcSEcCtD
Telmisartan—PPARG—Gene Expression—U2AF2—multiple sclerosis	0.000132	0.00146	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—HNRNPA1—multiple sclerosis	0.000132	0.00146	CbGpPWpGaD
Telmisartan—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000132	0.000597	CcSEcCtD
Telmisartan—Dizziness—Prednisolone—multiple sclerosis	0.000131	0.000597	CcSEcCtD
Telmisartan—Asthenia—Triamcinolone—multiple sclerosis	0.000131	0.000595	CcSEcCtD
Telmisartan—Abdominal pain—Betamethasone—multiple sclerosis	0.000131	0.000595	CcSEcCtD
Telmisartan—Body temperature increased—Dexamethasone—multiple sclerosis	0.000131	0.000595	CcSEcCtD
Telmisartan—Abdominal pain—Dexamethasone—multiple sclerosis	0.000131	0.000595	CcSEcCtD
Telmisartan—Body temperature increased—Betamethasone—multiple sclerosis	0.000131	0.000595	CcSEcCtD
Telmisartan—Asthenia—Methylprednisolone—multiple sclerosis	0.000131	0.000594	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000131	0.00145	CbGpPWpGaD
Telmisartan—Insomnia—Prednisone—multiple sclerosis	0.000131	0.000593	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—IL10—multiple sclerosis	0.00013	0.00145	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	0.00013	0.00145	CbGpPWpGaD
Telmisartan—Paraesthesia—Prednisone—multiple sclerosis	0.00013	0.000589	CcSEcCtD
Telmisartan—Pruritus—Triamcinolone—multiple sclerosis	0.000129	0.000587	CcSEcCtD
Telmisartan—Cough—Methotrexate—multiple sclerosis	0.000129	0.000586	CcSEcCtD
Telmisartan—Pruritus—Methylprednisolone—multiple sclerosis	0.000129	0.000586	CcSEcCtD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—multiple sclerosis	0.000128	0.00143	CbGpPWpGaD
Telmisartan—Dyspepsia—Prednisone—multiple sclerosis	0.000127	0.000577	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—IL4—multiple sclerosis	0.000127	0.00141	CbGpPWpGaD
Telmisartan—Myalgia—Methotrexate—multiple sclerosis	0.000126	0.000572	CcSEcCtD
Telmisartan—Arthralgia—Methotrexate—multiple sclerosis	0.000126	0.000572	CcSEcCtD
Telmisartan—Chest pain—Methotrexate—multiple sclerosis	0.000126	0.000572	CcSEcCtD
Telmisartan—Decreased appetite—Prednisone—multiple sclerosis	0.000126	0.00057	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—CCR1—multiple sclerosis	0.000125	0.00139	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000125	0.00139	CbGpPWpGaD
Telmisartan—Rash—Prednisolone—multiple sclerosis	0.000125	0.000569	CcSEcCtD
Telmisartan—Dermatitis—Prednisolone—multiple sclerosis	0.000125	0.000568	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000125	0.000568	CcSEcCtD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000125	0.00139	CbGpPWpGaD
Telmisartan—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000125	0.000566	CcSEcCtD
Telmisartan—Fatigue—Prednisone—multiple sclerosis	0.000125	0.000565	CcSEcCtD
Telmisartan—Headache—Prednisolone—multiple sclerosis	0.000125	0.000565	CcSEcCtD
Telmisartan—Discomfort—Methotrexate—multiple sclerosis	0.000124	0.000565	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	0.000124	0.00138	CbGpPWpGaD
Telmisartan—Constipation—Prednisone—multiple sclerosis	0.000124	0.000561	CcSEcCtD
Telmisartan—Dizziness—Triamcinolone—multiple sclerosis	0.000121	0.000549	CcSEcCtD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000121	0.00134	CbGpPWpGaD
Telmisartan—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000121	0.000548	CcSEcCtD
Telmisartan—Dizziness—Methylprednisolone—multiple sclerosis	0.000121	0.000547	CcSEcCtD
Telmisartan—Infection—Methotrexate—multiple sclerosis	0.00012	0.000544	CcSEcCtD
Telmisartan—Feeling abnormal—Prednisone—multiple sclerosis	0.000119	0.00054	CcSEcCtD
Telmisartan—Asthenia—Dexamethasone—multiple sclerosis	0.000119	0.00054	CcSEcCtD
Telmisartan—Asthenia—Betamethasone—multiple sclerosis	0.000119	0.00054	CcSEcCtD
Telmisartan—PPARG—Generic Transcription Pathway—PGR—multiple sclerosis	0.000119	0.00132	CbGpPWpGaD
Telmisartan—Nervous system disorder—Methotrexate—multiple sclerosis	0.000118	0.000537	CcSEcCtD
Telmisartan—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000118	0.000536	CcSEcCtD
Telmisartan—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000118	0.000536	CcSEcCtD
Telmisartan—Nausea—Prednisolone—multiple sclerosis	0.000118	0.000536	CcSEcCtD
Telmisartan—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000117	0.00131	CbGpPWpGaD
Telmisartan—Pruritus—Betamethasone—multiple sclerosis	0.000117	0.000533	CcSEcCtD
Telmisartan—Pruritus—Dexamethasone—multiple sclerosis	0.000117	0.000533	CcSEcCtD
Telmisartan—Skin disorder—Methotrexate—multiple sclerosis	0.000117	0.000532	CcSEcCtD
Telmisartan—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000117	0.00053	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—FAS—multiple sclerosis	0.000117	0.0013	CbGpPWpGaD
Telmisartan—Vomiting—Triamcinolone—multiple sclerosis	0.000116	0.000528	CcSEcCtD
Telmisartan—Vomiting—Methylprednisolone—multiple sclerosis	0.000116	0.000526	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	0.000116	0.00129	CbGpPWpGaD
Telmisartan—Rash—Triamcinolone—multiple sclerosis	0.000115	0.000523	CcSEcCtD
Telmisartan—Dermatitis—Triamcinolone—multiple sclerosis	0.000115	0.000523	CcSEcCtD
Telmisartan—Anorexia—Methotrexate—multiple sclerosis	0.000115	0.000522	CcSEcCtD
Telmisartan—Rash—Methylprednisolone—multiple sclerosis	0.000115	0.000522	CcSEcCtD
Telmisartan—AGTR1—Signaling Pathways—TAGAP—multiple sclerosis	0.000115	0.00128	CbGpPWpGaD
Telmisartan—Dermatitis—Methylprednisolone—multiple sclerosis	0.000115	0.000522	CcSEcCtD
Telmisartan—Urticaria—Prednisone—multiple sclerosis	0.000115	0.000521	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	0.000115	0.00127	CbGpPWpGaD
Telmisartan—Headache—Triamcinolone—multiple sclerosis	0.000115	0.00052	CcSEcCtD
Telmisartan—Headache—Methylprednisolone—multiple sclerosis	0.000114	0.000519	CcSEcCtD
Telmisartan—Abdominal pain—Prednisone—multiple sclerosis	0.000114	0.000518	CcSEcCtD
Telmisartan—Body temperature increased—Prednisone—multiple sclerosis	0.000114	0.000518	CcSEcCtD
Telmisartan—Diarrhoea—Betamethasone—multiple sclerosis	0.000114	0.000515	CcSEcCtD
Telmisartan—Diarrhoea—Dexamethasone—multiple sclerosis	0.000114	0.000515	CcSEcCtD
Telmisartan—Hypotension—Methotrexate—multiple sclerosis	0.000113	0.000512	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—CCL5—multiple sclerosis	0.000113	0.00125	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CYP27B1—multiple sclerosis	0.000112	0.00124	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CYP24A1—multiple sclerosis	0.000112	0.00124	CbGpPWpGaD
Telmisartan—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.00011	0.000499	CcSEcCtD
Telmisartan—ABCC2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.00011	0.00122	CbGpPWpGaD
Telmisartan—Dizziness—Betamethasone—multiple sclerosis	0.00011	0.000498	CcSEcCtD
Telmisartan—Dizziness—Dexamethasone—multiple sclerosis	0.00011	0.000498	CcSEcCtD
Telmisartan—Insomnia—Methotrexate—multiple sclerosis	0.000109	0.000496	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000109	0.00121	CbGpPWpGaD
Telmisartan—Nausea—Triamcinolone—multiple sclerosis	0.000109	0.000493	CcSEcCtD
Telmisartan—Paraesthesia—Methotrexate—multiple sclerosis	0.000108	0.000492	CcSEcCtD
Telmisartan—Nausea—Methylprednisolone—multiple sclerosis	0.000108	0.000492	CcSEcCtD
Telmisartan—Dyspnoea—Methotrexate—multiple sclerosis	0.000108	0.000489	CcSEcCtD
Telmisartan—Somnolence—Methotrexate—multiple sclerosis	0.000107	0.000487	CcSEcCtD
Telmisartan—PPARG—Developmental Biology—PTPRC—multiple sclerosis	0.000107	0.00119	CbGpPWpGaD
Telmisartan—Hypersensitivity—Prednisone—multiple sclerosis	0.000106	0.000483	CcSEcCtD
Telmisartan—Dyspepsia—Methotrexate—multiple sclerosis	0.000106	0.000482	CcSEcCtD
Telmisartan—Vomiting—Dexamethasone—multiple sclerosis	0.000105	0.000479	CcSEcCtD
Telmisartan—Vomiting—Betamethasone—multiple sclerosis	0.000105	0.000479	CcSEcCtD
Telmisartan—Decreased appetite—Methotrexate—multiple sclerosis	0.000105	0.000476	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	0.000105	0.00116	CbGpPWpGaD
Telmisartan—Rash—Betamethasone—multiple sclerosis	0.000105	0.000475	CcSEcCtD
Telmisartan—Rash—Dexamethasone—multiple sclerosis	0.000105	0.000475	CcSEcCtD
Telmisartan—Dermatitis—Dexamethasone—multiple sclerosis	0.000105	0.000474	CcSEcCtD
Telmisartan—Dermatitis—Betamethasone—multiple sclerosis	0.000105	0.000474	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000104	0.000473	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000104	0.00116	CbGpPWpGaD
Telmisartan—Fatigue—Methotrexate—multiple sclerosis	0.000104	0.000472	CcSEcCtD
Telmisartan—PPARG—Gene Expression—ZFP36L1—multiple sclerosis	0.000104	0.00116	CbGpPWpGaD
Telmisartan—Headache—Dexamethasone—multiple sclerosis	0.000104	0.000472	CcSEcCtD
Telmisartan—Headache—Betamethasone—multiple sclerosis	0.000104	0.000472	CcSEcCtD
Telmisartan—Asthenia—Prednisone—multiple sclerosis	0.000104	0.00047	CcSEcCtD
Telmisartan—Pain—Methotrexate—multiple sclerosis	0.000103	0.000469	CcSEcCtD
Telmisartan—Pruritus—Prednisone—multiple sclerosis	0.000102	0.000464	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism—GPC5—multiple sclerosis	0.000102	0.00113	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000102	0.00113	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—CCR5—multiple sclerosis	0.000101	0.00113	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—S1PR1—multiple sclerosis	0.0001	0.00112	CbGpPWpGaD
Telmisartan—Feeling abnormal—Methotrexate—multiple sclerosis	9.95e-05	0.000452	CcSEcCtD
Telmisartan—Diarrhoea—Prednisone—multiple sclerosis	9.89e-05	0.000449	CcSEcCtD
Telmisartan—Gastrointestinal pain—Methotrexate—multiple sclerosis	9.87e-05	0.000448	CcSEcCtD
Telmisartan—Nausea—Dexamethasone—multiple sclerosis	9.85e-05	0.000447	CcSEcCtD
Telmisartan—Nausea—Betamethasone—multiple sclerosis	9.85e-05	0.000447	CcSEcCtD
Telmisartan—ABCG2—Metabolism—SRM—multiple sclerosis	9.85e-05	0.00109	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—GPC5—multiple sclerosis	9.78e-05	0.00109	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—STAT3—multiple sclerosis	9.74e-05	0.00108	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	9.7e-05	0.00108	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—CD80—multiple sclerosis	9.68e-05	0.00108	CbGpPWpGaD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	9.61e-05	0.00107	CbGpPWpGaD
Telmisartan—Urticaria—Methotrexate—multiple sclerosis	9.59e-05	0.000435	CcSEcCtD
Telmisartan—Dizziness—Prednisone—multiple sclerosis	9.55e-05	0.000434	CcSEcCtD
Telmisartan—ABCG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	9.55e-05	0.00106	CbGpPWpGaD
Telmisartan—Body temperature increased—Methotrexate—multiple sclerosis	9.55e-05	0.000433	CcSEcCtD
Telmisartan—Abdominal pain—Methotrexate—multiple sclerosis	9.55e-05	0.000433	CcSEcCtD
Telmisartan—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.52e-05	0.00106	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP24A1—multiple sclerosis	9.52e-05	0.00106	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP27B1—multiple sclerosis	9.52e-05	0.00106	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PTGER4—multiple sclerosis	9.47e-05	0.00105	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	9.3e-05	0.00103	CbGpPWpGaD
Telmisartan—Vomiting—Prednisone—multiple sclerosis	9.19e-05	0.000417	CcSEcCtD
Telmisartan—AGTR1—GPCR downstream signaling—CXCR3—multiple sclerosis	9.15e-05	0.00102	CbGpPWpGaD
Telmisartan—Rash—Prednisone—multiple sclerosis	9.11e-05	0.000413	CcSEcCtD
Telmisartan—Dermatitis—Prednisone—multiple sclerosis	9.1e-05	0.000413	CcSEcCtD
Telmisartan—Headache—Prednisone—multiple sclerosis	9.05e-05	0.000411	CcSEcCtD
Telmisartan—PPARG—Adipogenesis—TGFB1—multiple sclerosis	9.03e-05	0.001	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CCL3—multiple sclerosis	8.94e-05	0.000993	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CCR2—multiple sclerosis	8.9e-05	0.000989	CbGpPWpGaD
Telmisartan—Hypersensitivity—Methotrexate—multiple sclerosis	8.9e-05	0.000404	CcSEcCtD
Telmisartan—PPARG—Metabolism—GPC5—multiple sclerosis	8.7e-05	0.000968	CbGpPWpGaD
Telmisartan—Asthenia—Methotrexate—multiple sclerosis	8.66e-05	0.000393	CcSEcCtD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.63e-05	0.000959	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.63e-05	0.000959	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.62e-05	0.000958	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PTGER4—multiple sclerosis	8.6e-05	0.000956	CbGpPWpGaD
Telmisartan—Nausea—Prednisone—multiple sclerosis	8.58e-05	0.000389	CcSEcCtD
Telmisartan—AGTR1—Signaling Pathways—RGS1—multiple sclerosis	8.54e-05	0.00095	CbGpPWpGaD
Telmisartan—Pruritus—Methotrexate—multiple sclerosis	8.54e-05	0.000388	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism—RRM1—multiple sclerosis	8.45e-05	0.00094	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.44e-05	0.000938	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—TNF—multiple sclerosis	8.43e-05	0.000937	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	8.38e-05	0.000931	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—VDR—multiple sclerosis	8.32e-05	0.000925	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CXCR3—multiple sclerosis	8.31e-05	0.000924	CbGpPWpGaD
Telmisartan—Diarrhoea—Methotrexate—multiple sclerosis	8.26e-05	0.000375	CcSEcCtD
Telmisartan—AGTR1—GPCR downstream signaling—CNR1—multiple sclerosis	8.21e-05	0.000913	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—GPR65—multiple sclerosis	8.1e-05	0.000901	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CCR2—multiple sclerosis	8.08e-05	0.000898	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—PABPC1—multiple sclerosis	8.07e-05	0.000897	CbGpPWpGaD
Telmisartan—Dizziness—Methotrexate—multiple sclerosis	7.98e-05	0.000362	CcSEcCtD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	7.95e-05	0.000884	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—POMC—multiple sclerosis	7.93e-05	0.000882	CbGpPWpGaD
Telmisartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	7.79e-05	0.000866	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—CCL2—multiple sclerosis	7.76e-05	0.000863	CbGpPWpGaD
Telmisartan—Vomiting—Methotrexate—multiple sclerosis	7.68e-05	0.000348	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	7.65e-05	0.000851	CbGpPWpGaD
Telmisartan—Rash—Methotrexate—multiple sclerosis	7.61e-05	0.000345	CcSEcCtD
Telmisartan—Dermatitis—Methotrexate—multiple sclerosis	7.61e-05	0.000345	CcSEcCtD
Telmisartan—Headache—Methotrexate—multiple sclerosis	7.56e-05	0.000343	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—CNR1—multiple sclerosis	7.46e-05	0.000829	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CXCL13—multiple sclerosis	7.41e-05	0.000824	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCR1—multiple sclerosis	7.41e-05	0.000824	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CXCL10—multiple sclerosis	7.39e-05	0.000822	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—RPL5—multiple sclerosis	7.28e-05	0.000809	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—RRM1—multiple sclerosis	7.21e-05	0.000802	CbGpPWpGaD
Telmisartan—Nausea—Methotrexate—multiple sclerosis	7.17e-05	0.000325	CcSEcCtD
Telmisartan—ABCG2—Metabolism—CYP24A1—multiple sclerosis	6.94e-05	0.000771	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP27B1—multiple sclerosis	6.94e-05	0.000771	CbGpPWpGaD
Telmisartan—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	6.9e-05	0.000767	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	6.82e-05	0.000759	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—IL6—multiple sclerosis	6.81e-05	0.000757	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL2—multiple sclerosis	6.8e-05	0.000756	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	6.73e-05	0.000748	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CXCL10—multiple sclerosis	6.72e-05	0.000747	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.56e-05	0.000729	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.53e-05	0.000726	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CCL5—multiple sclerosis	6.37e-05	0.000708	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GPC5—multiple sclerosis	6.35e-05	0.000706	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	6.11e-05	0.000679	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CCL5—multiple sclerosis	5.78e-05	0.000643	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	5.76e-05	0.00064	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CCR5—multiple sclerosis	5.73e-05	0.000638	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—PGR—multiple sclerosis	5.73e-05	0.000637	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—IL2RA—multiple sclerosis	5.65e-05	0.000628	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.63e-05	0.000626	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.6e-05	0.000622	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SRM—multiple sclerosis	5.46e-05	0.000606	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SRM—multiple sclerosis	5.32e-05	0.000592	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	5.3e-05	0.00059	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCL3—multiple sclerosis	5.28e-05	0.000587	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—RRM1—multiple sclerosis	5.26e-05	0.000585	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CCR5—multiple sclerosis	5.21e-05	0.000579	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.16e-05	0.000574	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.14e-05	0.000571	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL2RA—multiple sclerosis	5.13e-05	0.000571	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTGER4—multiple sclerosis	5.08e-05	0.000565	CbGpPWpGaD
Telmisartan—CYP2C19—Biological oxidations—POMC—multiple sclerosis	5.06e-05	0.000562	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PGR—multiple sclerosis	5e-05	0.000556	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—TNF—multiple sclerosis	4.95e-05	0.00055	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CXCR3—multiple sclerosis	4.91e-05	0.000546	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.88e-05	0.000543	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CD28—multiple sclerosis	4.86e-05	0.00054	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—BCHE—multiple sclerosis	4.85e-05	0.00054	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.81e-05	0.000534	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—IL6—multiple sclerosis	4.8e-05	0.000534	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TYK2—multiple sclerosis	4.78e-05	0.000532	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCR2—multiple sclerosis	4.77e-05	0.000531	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.56e-05	0.000507	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—POMC—multiple sclerosis	4.48e-05	0.000498	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CNR1—multiple sclerosis	4.41e-05	0.00049	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.38e-05	0.000487	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—BCHE—multiple sclerosis	4.14e-05	0.000461	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—POMC—multiple sclerosis	4.07e-05	0.000452	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—VDR—multiple sclerosis	4e-05	0.000445	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CCL2—multiple sclerosis	3.98e-05	0.000443	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CXCL10—multiple sclerosis	3.97e-05	0.000441	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	3.84e-05	0.000427	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	3.84e-05	0.000427	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MMP9—multiple sclerosis	3.77e-05	0.000419	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.76e-05	0.000418	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP27B1—multiple sclerosis	3.75e-05	0.000417	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP24A1—multiple sclerosis	3.75e-05	0.000417	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—TYK2—multiple sclerosis	3.62e-05	0.000402	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GPC5—multiple sclerosis	3.52e-05	0.000391	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.49e-05	0.000388	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CD86—multiple sclerosis	3.47e-05	0.000386	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GPC5—multiple sclerosis	3.43e-05	0.000381	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCL5—multiple sclerosis	3.41e-05	0.00038	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—STAT3—multiple sclerosis	3.35e-05	0.000372	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—IL2—multiple sclerosis	3.31e-05	0.000368	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—MYC—multiple sclerosis	3.31e-05	0.000367	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SPP1—multiple sclerosis	3.16e-05	0.000352	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TGFB1—multiple sclerosis	3.1e-05	0.000345	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCR5—multiple sclerosis	3.08e-05	0.000342	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MAPK1—multiple sclerosis	3.04e-05	0.000338	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.04e-05	0.000338	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL2RA—multiple sclerosis	3.03e-05	0.000337	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—BCHE—multiple sclerosis	3.02e-05	0.000336	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL2—multiple sclerosis	3.01e-05	0.000335	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—APOE—multiple sclerosis	2.92e-05	0.000325	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.91e-05	0.000324	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TNF—multiple sclerosis	2.9e-05	0.000322	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—RRM1—multiple sclerosis	2.84e-05	0.000316	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—APOE—multiple sclerosis	2.8e-05	0.000311	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.62e-05	0.000292	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.62e-05	0.000291	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.57e-05	0.000285	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CD80—multiple sclerosis	2.53e-05	0.000281	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—POMC—multiple sclerosis	2.51e-05	0.000279	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—APOE—multiple sclerosis	2.49e-05	0.000277	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.44e-05	0.000272	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—POMC—multiple sclerosis	2.4e-05	0.000267	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCL2—multiple sclerosis	2.35e-05	0.000262	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—IL6—multiple sclerosis	2.34e-05	0.00026	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—MAPK1—multiple sclerosis	2.3e-05	0.000256	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ALB—multiple sclerosis	2.29e-05	0.000254	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.26e-05	0.000251	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—POMC—multiple sclerosis	2.14e-05	0.000238	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TYK2—multiple sclerosis	2.14e-05	0.000237	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ALB—multiple sclerosis	1.95e-05	0.000217	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.94e-05	0.000216	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—APOE—multiple sclerosis	1.82e-05	0.000202	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL2—multiple sclerosis	1.78e-05	0.000198	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.77e-05	0.000197	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL6—multiple sclerosis	1.77e-05	0.000197	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MMP9—multiple sclerosis	1.68e-05	0.000187	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.67e-05	0.000186	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.64e-05	0.000183	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—BCHE—multiple sclerosis	1.63e-05	0.000182	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MYC—multiple sclerosis	1.59e-05	0.000177	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—POMC—multiple sclerosis	1.56e-05	0.000174	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—STAT3—multiple sclerosis	1.5e-05	0.000166	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ALB—multiple sclerosis	1.42e-05	0.000158	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MYC—multiple sclerosis	1.39e-05	0.000155	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TGFB1—multiple sclerosis	1.39e-05	0.000154	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MAPK1—multiple sclerosis	1.36e-05	0.000151	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL6—multiple sclerosis	1.04e-05	0.000116	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—APOE—multiple sclerosis	1.01e-05	0.000112	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—APOE—multiple sclerosis	9.82e-06	0.000109	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—POMC—multiple sclerosis	8.65e-06	9.61e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—POMC—multiple sclerosis	8.44e-06	9.38e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALB—multiple sclerosis	7.88e-06	8.76e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALB—multiple sclerosis	7.69e-06	8.55e-05	CbGpPWpGaD
